Loading clinical trials...
Loading clinical trials...
Dual-layer Spectral Computerized Tomography for Breast Cancer Detection in Women With Dense Breasts: a Single Centre, Feasibility Study - The DECREAS Study
The main objective of this project is to demonstrate the feasibility of DLSCT to detect breast cancer in women with dense breasts. Patients with locoregional advanced primary breast cancer and heterogeneously (n = 7) or extremely dense breasts (n = 7) as determined by mammography will be included in this study. These patients have an indication for a positron emission tomography computed tomography (PET-CT) scan to search for distant metastases. In this study the participants will undergo an additional contrast enhanced DLSCT scan to determine the feasibility of spectral CT to detect breast cancer in women with dense breasts.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Rijnstate Hospital
Arnhem, Netherlands
Start Date
January 1, 2022
Primary Completion Date
January 1, 2023
Completion Date
January 1, 2023
Last Updated
January 6, 2022
14
ESTIMATED participants
Dual-layer spectral computerized tomography (DLSCT)
DIAGNOSTIC_TEST
Lead Sponsor
Rijnstate Hospital
NCT07191730
NCT06797635
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions